Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia

被引:29
|
作者
Silver, Michael [1 ]
Factor, Stewart A. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Neurol, Wesley Woods Hlth Ctr, Atlanta, GA 30329 USA
关键词
Valproic acid; Valproate; Parkinsonism; Dyskinesia; REVERSIBLE PARKINSONISM; SODIUM VALPROATE; EPILEPSY;
D O I
10.1016/j.parkreldis.2013.03.016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Valproic acid is a drug used for the treatment of a variety of psychiatric and neurological disorders. While it is well known to cause postural tremor, hyperammonemia, slowness, and sedation, it has also been described to occasionally cause a reversible form of parkinsonism. Materials and methods: A series of five cases is reported. Results: All patients were taking the drug for at least several months before onset of their parkinsonian symptoms. Parkinsonism was defined by the presence of bradykinesia, rigidity, postural instability, and resting tremor, but not postural or action tremor. After discontinuing their valproic acid, improvement was seen by all patients. The course of improvement took days to months after discontinuance. Two of these patients responded to dopaminergic therapy, with drug-induced dyskinesia observed in one. In another patient, valproic acid was thought to unmask underlying Parkinson's Disease; this patient benefited from levodopa as well. Conclusion: Valproic acid-induced parkinsonism can look identical to idiopathic parkinsonism. In all five cases, the relationship between the valproic acid use and parkinsonism was initially unclear because of the delayed and insidious onset. Our finding of levodopa responsiveness and dyskinesia added to the diagnostic confusion. This treatment responsiveness also set it apart from neuroleptic-induced parkinsonism. In all cases improvement of symptoms occurred after discontinuation of the offending medication. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:758 / 760
页数:3
相关论文
共 50 条
  • [31] Valproic acid-induced serious side effects
    Affes, H.
    Hammami, S.
    Ghozzi, H.
    Sahnoun, Z.
    Hakim, A.
    Ksouda, K.
    Ben Mahmoud, L.
    Zeghal, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 80 - 80
  • [32] Carnitine in the treatment of valproic acid-induced toxicity
    Lheureux, P. E. R.
    Hantson, P.
    CLINICAL TOXICOLOGY, 2008, 46 (05) : 402 - 402
  • [33] Levodopa responsiveness in disorders with parkinsonism: A review of the literature
    Constantinescu, Radu
    Richard, Irene
    Kurlan, Roger
    MOVEMENT DISORDERS, 2007, 22 (15) : 2141 - 2148
  • [34] Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism
    Goyal, Sheetal
    Kamble, Nitish
    Mudabbir, Ma Mukheem
    Bhattacharya, Amitabh
    Yadav, Ravi
    Pal, PramodKumar
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (06) : 1075 - 1079
  • [35] Reply to: "Levodopa-Induced Dyskinesia Is Mediated by Cortical Gamma Oscillations in Experimental Parkinsonism"
    Guettler, Christopher
    Nikulin, Vadim V.
    van Riesen, Christoph
    MOVEMENT DISORDERS, 2021, 36 (04) : 1045 - 1047
  • [36] Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation
    Li, Michael H.
    Mestre, Tiago A.
    Fox, Susan H.
    Taati, Babak
    JOURNAL OF NEUROENGINEERING AND REHABILITATION, 2018, 15
  • [37] Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation
    Michael H. Li
    Tiago A. Mestre
    Susan H. Fox
    Babak Taati
    Journal of NeuroEngineering and Rehabilitation, 15
  • [38] Levodopa-induced dyskinesia in Atypical Parkinsonism: A population-based cohort study
    Turcano, Pierpaolo
    Stang, Cole
    Bower, James
    Wennberg, Alexandra
    Ahlskog, J.
    Mielke, Michelle
    Savica, Rodolfo
    NEUROLOGY, 2019, 92 (15)
  • [39] Treatment of valproic acid-induced encephalopathy with carbalagenic acid Reply
    Jose Nava-Mateos, Juan
    Roiz-Rey, Patricia
    Diaz Alvarez-Mediavilla, Jorge
    Cebrian-Novella, Diego
    Gomez-Del Olmo, Vicente
    Ceberio-Hualde, Leticia
    REVISTA DE NEUROLOGIA, 2018, 66 (04) : 136 - 136
  • [40] Topiramate increases the risk of valproic acid-induced encephalopathy
    Noh, Young
    Kim, Dong Wook
    Chu, Kon
    Lee, Soon-Tae
    Jung, Keun-Hwa
    Moon, Hye-Jin
    Lee, Sang Kun
    EPILEPSIA, 2013, 54 (01) : e1 - e4